Equillium EQ
NASDAQ EQ
$1.42 -0.04 (-2.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Equillium (EQ) Non-Current Deferred Revenue (2022 - 2023)

Updated

Equillium (EQ) reported Non-Current Deffered Revenue of $2.42 million for Q3 2023, down 59.4% from the prior quarter.

Analysis

Equillium (EQ) Non-Current Deferred Revenue (2022 - 2023) Analysis & Trends

At the end of FY2022, Equillium posted Non-Current Deffered Revenue of $10.38 million.

  • Per Business Quant data, the three quarters before Q3 2023 came in at $5.96 million (Q2 2023), $7.94 million (Q1 2023) and $10.38 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Equillium 163.24 Mn -18.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.42 Mn
Jun 30, 2023 5.96 Mn
Mar 31, 2023 7.94 Mn
Dec 31, 2022 10.38 Mn
API Access

Equillium Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EQ&period=max&api_key=YOUR_API_KEY